Fowl Cholera in Poultry: Pasteurella Multocida Pathogenesis, Clinical Signs, and Outbreak Management

Introduction

Fowl cholera is a highly contagious, septicemic bacterial disease of domestic and wild avian species caused by the gram-negative coccobacillus Pasteurella multocida [1, 2]. The disease is classified under the World Organisation for Animal Health (WOAH) as a notifiable infection in poultry and represents a significant economic burden to the commercial poultry industry worldwide [3, 4]. P. multocida is a member of the family Pasteurellaceae and is characterized by its bipolar staining properties and its ability to produce a potent polysaccharide capsule [5]. The organism is classified into five capsular serogroups (A, B, D, E, and F) and 16 somatic serotypes based on the Heddleston scheme [6]. In poultry, the vast majority of fowl cholera outbreaks are attributed to capsular serogroup A, with serogroup F also reported in some geographic regions [7, 8]. The disease can manifest in peracute, acute, or chronic forms, with the acute presentation being the most common in commercial flocks [9].

Etiology and Taxonomy

Pasteurella multocida is a facultative anaerobic, non-motile, non-spore-forming bacterium that exhibits a characteristic bipolar staining when treated with methylene blue or Giemsa stain [10]. The organism is oxidase positive, catalase positive, and reduces nitrates [11]. The species is divided into three subspecies: P. multocida subsp. multocida, P. multocida subsp. septica, and P. multocida subsp. gallicida [12]. The gallicida subspecies is most frequently isolated from avian sources [13]. The complete genome of P. multocida has been sequenced, revealing a genome size of approximately 2.3 Mb with a GC content of 40.4% [14]. The genome encodes for a range of virulence factors including adhesins, toxins, and iron acquisition systems [15].

Pathogenesis and Virulence Factors

The pathogenesis of fowl cholera is a multifactorial process involving both bacterial and host determinants. The primary virulence factor of P. multocida is the hyaluronic acid capsule, which is essential for the establishment of systemic infection [16]. The capsule is composed of hyaluronic acid, a polymer of N-acetylglucosamine and glucuronic acid, which is synthesized by the products of the hya operon [17]. The capsule provides resistance to phagocytosis and complement-mediated killing in avian serum [18]. The hyaD gene has been shown to contribute directly to the virulence of avian P. multocida strains [19]. The stringent response, mediated by the RelA protein, acts as a negative regulator of hyaluronic acid capsule production, indicating that capsule expression is tightly controlled under nutrient-limited conditions [20].

The lipopolysaccharide (LPS) of P. multocida is a second critical virulence determinant [21]. The LPS structure is highly heterogeneous and undergoes phase variation, which is associated with the emergence of outbreak strains on free-range layer farms [22]. The LPS outer core is synthesized by the products of the pcgD and hptE genes, which encode transferases for the addition of galactose and heptose residues, respectively [23]. A truncated LPS outer core structure results in significant attenuation of virulence in ducks [24]. The LPS molecule also activates the host inflammatory response through the interaction with Toll-like receptor 4 (TLR4), leading to the induction of necroptosis and apoptosis in hepatocytes [25].

Filamentous hemagglutinins (FHA) are large, surface-exposed proteins that mediate adherence to host epithelial cells [26]. The fhaB1 and fhaB2 genes encode for two distinct FHA proteins in P. multocida [27]. The fhaB2 gene has been demonstrated to be essential for virulence in turkeys, while fhaB1 is not involved in fowl cholera pathogenesis in turkey poults [28]. The outer membrane protein H (OmpH) is a porin that functions as an immunogenic surface antigen and is a target for vaccine development [29]. The ompA gene encodes for another major outer membrane protein that exhibits significant genetic diversity among avian isolates [30].

Clinical Signs and Disease Presentation

Fowl cholera can present in three distinct clinical forms: peracute, acute, and chronic [31]. The peracute form is characterized by sudden death in apparently healthy birds with no premonitory signs [32]. Mortality in peracute outbreaks can reach 100% in susceptible flocks within 24 to 48 hours [33]. The acute form is the most commonly observed presentation and is characterized by fever, depression, anorexia, and mucoid discharge from the oral cavity and nares [34]. Affected birds exhibit cyanosis of the comb and wattles, which is a direct consequence of septicemic shock and reduced peripheral perfusion [35]. Respiratory signs include dyspnea and rales due to the accumulation of exudate in the upper respiratory tract [36]. Diarrhea is a frequent finding, with feces ranging from watery to greenish-yellow in color [37].

The chronic form of fowl cholera is characterized by localized infections, including swollen wattles, joints, and footpads [38]. Chronic infections are more common in older birds and in flocks with partial immunity [39]. The disease can also present as a localized infection of the respiratory tract, leading to sinusitis and conjunctivitis [40]. In turkeys, the disease is particularly severe, with coinfection by Mycoplasmoides gallisepticum exacerbating the clinical presentation and increasing mortality rates [41].

Pathological Lesions

The gross pathological lesions of acute fowl cholera are highly characteristic and include petechial and ecchymotic hemorrhages on the serosal surfaces of the heart, liver, and gizzard [42]. The liver is typically enlarged, friable, and exhibits a mottled appearance with multiple small, white to yellow necrotic foci [43]. This hepatic lesion is pathognomonic for fowl cholera and is the result of bacterial embolization and hepatocellular necrosis [44]. The spleen is enlarged and congested, and the lungs may show evidence of congestion and edema [45]. The pericardial sac is often distended with a serofibrinous exudate, and the air sacs may be thickened and opaque [46]. In chronic cases, the primary lesion is a caseous, purulent exudate within the wattles and joints [47].

Diagnostic Approaches

The diagnosis of fowl cholera is based on a combination of clinical history, gross pathology, and laboratory confirmation [48]. The gold standard for diagnosis is the isolation of P. multocida from the liver, spleen, or bone marrow of affected birds on blood agar or tryptic soy agar [49]. The organism produces characteristic smooth, mucoid colonies that are 1 to 2 mm in diameter after 24 hours of incubation at 37 degrees Celsius [50]. The colonies exhibit a distinctive iridescent sheen when viewed under oblique transmitted light, which is a property associated with the presence of the hyaluronic acid capsule [51].

Molecular diagnostic methods have largely replaced traditional culture-based methods for rapid detection [52]. The polymerase chain reaction (PCR) targeting the kmt1 gene, which encodes the P. multocida specific 16S rRNA, is the most widely used molecular assay [53]. A comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays has demonstrated that both methods have high sensitivity and specificity, with LAMP offering the advantage of rapid, field-deployable detection [54]. The 5' Taq nuclease assay (real-time PCR) provides a quantitative approach for the detection of P. multocida in clinical samples [55]. Fluorescent in situ hybridization (FISH) using rRNA-targeted probes has been developed for the direct visualization of P. multocida in tissue sections [56].

Serological typing is performed using the Heddleston scheme, which is based on the heat-stable somatic antigens [57]. The indirect ELISA using recombinant OmpH as the coating antigen has been developed for the detection of anti-P. multocida antibodies in ducks and chickens [58]. The multi-locus sequence typing (MLST) scheme for avian P. multocida isolates provides a high-resolution tool for epidemiological investigations [59].

Outbreak Management

The management of a fowl cholera outbreak requires a multi-pronged approach that includes biosecurity, depopulation, and vaccination [60]. The first step in an outbreak is the immediate quarantine of the affected flock and the restriction of movement of personnel and equipment [61]. The affected birds should be humanely euthanized, and the carcasses should be disposed of by incineration or deep burial [62]. The poultry house should be thoroughly cleaned and disinfected with a 2% sodium hydroxide solution or a 1% formalin solution. A downtime period of at least 14 days is recommended before the introduction of new birds.

Vaccination is the primary tool for the prevention of fowl cholera in endemic areas. Both live attenuated and inactivated vaccines are available for use in poultry. The live attenuated vaccines are typically derived from the serial passage of virulent strains, such as the PMZ8 strain in ducks. The inactivated vaccines are formulated with bacterins or recombinant antigens and are adjuvanted with aluminum hydroxide or oil emulsions. The gamma-irradiated fowl cholera vaccines have been shown to induce robust antibody responses and cytokine expression in chickens. The hydrogel-based inactivated vaccines provide a sustained release of antigen and have been shown to improve the immunoprotective effect.

Antimicrobial therapy is used for the treatment of affected birds and for the prevention of secondary infections in contact flocks. The most commonly used antimicrobials for fowl cholera are florfenicol, oxytetracycline, and sulfonamides. The pharmacokinetics of florfenicol in P. multocida infected ducks show a prolonged half-life and increased tissue penetration compared to healthy birds. The emergence of multidrug-resistant P. multocida strains is a growing concern, with resistance to tetracyclines, sulfonamides, and fluoroquinolones being reported. The genomic characterization of antimicrobial resistance in avian P. multocida has identified the presence of plasmid-borne resistance genes, including tetH, sul2, and strA.

Differential Diagnosis

Fowl cholera must be differentiated from other causes of acute septicemia in poultry, including highly pathogenic avian influenza (HPAI), Newcastle disease, and Escherichia coli septicemia. The presence of characteristic liver lesions and the isolation of P. multocida from the liver are the most reliable methods for differentiation. The disease can also be confused with Gallibacterium anatis infection, which produces similar pathological lesions in the reproductive tract.

Host Range and Zoonotic Potential

Pasteurella multocida is a zoonotic pathogen that can cause infection in humans following a bite or scratch from an infected animal. The most common presentation in humans is a localized wound infection that can progress to cellulitis and abscess formation. Systemic infections, including bacteremia and septicemia, are rare but have been reported in immunocompromised individuals. The risk of zoonotic transmission from poultry to humans is low, but it is a consideration for workers in the poultry industry who are in direct contact with infected birds.

Conclusion

Fowl cholera remains a significant threat to the global poultry industry due to its high mortality and the economic losses associated with outbreaks. The pathogenesis of the disease is driven by the hyaluronic acid capsule and the LPS, which are the primary virulence determinants. The diagnosis of fowl cholera is based on the isolation of P. multocida from the liver and the use of molecular methods for rapid detection. The management of outbreaks requires a combination of biosecurity, depopulation, and vaccination. The emergence of antimicrobial resistance in P. multocida is a growing concern that requires ongoing surveillance and the development of alternative control strategies.

graph TD
 A["Clinical Signs: Fever, Cyanosis, Diarrhea"] --> B{Postmortem Examination}
 B --> C["Liver: Necrotic Foci"]
 B --> D["Heart: Petechial Hemorrhages"]
 C --> E["Liver Swab: Blood Agar"]
 D --> E
 E --> F["Colony Morphology: Mucoid, Iridescent"]
 F --> G["Gram Stain: Bipolar Coccobacillus"]
 G --> H["PCR: kmt1 Gene"]
 H --> I["Serotyping: Heddleston Scheme"]
 I --> J["MLST: Epidemiological Typing"]
 J --> K[Antimicrobial Susceptibility Testing]
 K --> L["Treatment: Florfenicol, Oxytetracycline"]
 L --> M["Vaccination: Live Attenuated or Inactivated"]
 M --> N["Biosecurity: Quarantine, Disinfection"]

References

[1] Ji X, Meng Y, Yang H et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026.

[2] Miao F, Dai B, Li Z et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026.

[3] Gornatti-Churria CD, Jerry C, Ramsubeik S et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026.

[4] Chen J, Sun Y, Hu Y et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025.

[5] Miller I, Jerry C, Nguyen V et al. 100% Mortality in Commercial Slow-Growing Broiler Chickens with Acute Fowl Cholera. Avian Dis. 2025.

[6] Semmate N, Bamouh Z, Elkarhat Z et al. Isolation and Characterization of Pasteurella multocida A from an Outbreak in Turkeys in Morocco and Vaccine Preparation and Evaluation. Avian Dis. 2025.

[7] Dassanayake RP, Briggs RE, Kaplan BS et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025.

[8] Bathobakae L, Cho H, Philip S et al. Friend Turned Foe: Pasteurella multocida Bacteremia Following a Scratch by an Adopted Pekin Duck. J Investig Med High Impact Case Rep. 2025.

[9] Belay E, Bitew M, Ibrahim SM et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025.

[10] El-Tarabili RM, Enany ME, Alenzi AM et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025.

[11] Poussard M, Pant SD, Huang J et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025.

[12] Chung YC, Cheng LT, Chu CY et al. Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine. Avian Dis. 2024.

[13] Gao P, Wang L, Wang S et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024.

[14] Allen JL, Bushell RN, Noormohammadi AH et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024.

[15] Smallman TR, Williams GC, Harper M et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022.

[16] Omaleki L, Blackall PJ, Cuddihy T et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022.

[17] Zhao X, Yang F, Shen H et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022.

[18] Dessalegn B, Bitew M, Asfaw D et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Front Immunol. 2021.

[19] Saha O, Islam MR, Rahman MS et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021.

[20] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021.

[21] Xiao J, Li Y, Hu Z et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021.

[22] Reuben RC, Sarkar SL, Ibnat H et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Sci Rep. 2021.

[23] Smith E, Miller E, Aguayo JM et al. Genomic diversity and molecular epidemiology of Pasteurella multocida. PLoS One. 2021.

[24] Zhao X, Shen H, Liang S et al. The lipopolysaccharide outer core transferase genes pcgD and hptE contribute differently to the virulence of Pasteurella multocida in ducks. Vet Res. 2021.

[25] Hutcheson AR, Thompson K, Maurer JJ et al. Differentiating Vaccine-Related Fowl Cholera from Naturally Occurring Disease. Avian Dis. 2020.

[26] Li W, Tang Q, Dai N et al. Receptor-interacting serine/threonine kinase 1- and 3-dependent inflammation induced in lungs of chicken infected with Pasteurella multocida. Sci Rep. 2020.

[27] Omaleki L, Blackall PJ, Cuddihy T et al. Using genomics to understand inter- and intra- outbreak diversity of Pasteurella multocida isolates associated with fowl cholera in meat chickens. Microb Genom. 2020.

[28] Apinda N, Nambooppha B, Rittipornlertrak A et al. Protection against fowl cholera in ducks immunized with a combination vaccine containing live attenuated duck enteritis virus and recombinant outer membrane protein H of Pasteurella multocida. Avian Pathol. 2020.

[29] Blakey J, Shivaprasad HL, Crispo M et al. Retrospective Study of Pasteurella multocida Diagnosed in Commercial Turkeys Submitted to California Animal Health and Food Safety Laboratory System; 1991-2017. Avian Dis. 2018.

[30] Lan W, Xiao X, Jiang Y et al. Comparative pharmacokinetics of florfenicol in healthy and Pasteurella multocida-infected Gaoyou ducks. J Vet Pharmacol Ther. 2019.

[31] Luo Q, Kong L, Dong J et al. Protection of chickens against fowl cholera by supernatant proteins of Pasteurella multocida cultured in an iron-restricted medium. Avian Pathol. 2019.

[32] Blakey J, Crispo M, Bickford A et al. Fowl cholera and acute heart rupture in a backyard turkey. J Vet Diagn Invest. 2019.

[33] Varinrak T, Muenthaisong A, Apinda N et al. Construction and characterization of an OmpH-deficient mutant of Pasteurella multocida strain X-73. Avian Pathol. 2019.

[34] Li Z, Cheng F, Lan S et al. Investigation of genetic diversity and epidemiological characteristics of Pasteurella multocida isolates from poultry in southwest China by population structure, multi-locus sequence typing and virulence-associated gene profile analysis. J Vet Med Sci. 2018.

[35] Sellyei B, Thuma Á, Volokhov D et al. Comparative Analysis of Pasteurella multocida Isolates from Acute and Chronic Fowl Cholera Cases in Hungary During the Period 2005 Through 2010. Avian Dis. 2017.

[36] Tang Q, Li W, Dai N et al. The Role of Necroptosis, Apoptosis, and Inflammation in Fowl Cholera-Associated Liver Injury in a Chicken Model. Avian Dis. 2017.

[37] Poolperm P, Varinrak T, Kataoka Y et al. Development and standardization of an in-house indirect ELISA for detection of duck antibody to fowl cholera. J Microbiol Methods. 2017.

[38] Harper M, Boyce JD. The Myriad Properties of Pasteurella multocida Lipopolysaccharide. Toxins (Basel). 2017.

[39] Liu R, Chen C, Cheng L et al. Ducks as a potential reservoir for Pasteurella multocida infection detected using a new rOmpH-based ELISA. J Vet Med Sci. 2017.

[40] Varinrak T, Poolperm P, Sawada T et al. Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine. Avian Pathol. 2017.

[41] Pors SE, Chadfield MS, Sørensen DB et al. The origin of Pasteurella multocida impacts pathology and inflammation when assessed in a mouse model. Res Vet Sci. 2016.

[42] Yu C, Sizhu S, Luo Q et al. Genome sequencing of a virulent avian Pasteurella multocida strain GX-Pm reveals the candidate genes involved in the pathogenesis. Res Vet Sci. 2016.

[43] Harper M, John M, Edmunds M et al. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure. Vaccine. 2016.

[44] Furian TQ, Borges KA, Laviniki V et al. Virulence genes and antimicrobial resistance of Pasteurella multocida isolated from poultry and swine. Braz J Microbiol. 2016.

[45] Ghaffar A, Tariq A. In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo. Gene. 2016.

[46] Xiao K, Liu Q, Liu X et al. Identification of the Avian Pasteurella multocida phoP Gene and Evaluation of the Effects of phoP Deletion on Virulence and Immunogenicity. Int J Mol Sci. 2015.

[47] Thanasarasakulpong A, Poolperm P, Tankaew P et al. Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens. J Vet Med Sci. 2015.

[48] Salaheen S, Almario JA, Biswas D. Inhibition of growth and alteration of host cell interactions of Pasteurella multocida with natural byproducts. Poult Sci. 2014.

[49] Singh R, Remington B, Blackall P et al. Epidemiology of fowl cholera in free range broilers. Avian Dis. 2014.

[50] Jones KH, Thornton JK, Zhang Y et al. A 5-year retrospective report of Gallibacterium anatis and Pasteurella multocida isolates from chickens in Mississippi. Poult Sci. 2013.

[51] Singh R, Blackall PJ, Remington B et al. Studies on the presence and persistence of Pasteurella multocida serovars and genotypes in fowl cholera outbreaks. Avian Pathol. 2013.

[52] Mohamed MW, Mageed MA. Molecular analysis of Pasteurella multocida strains isolated from fowl cholera infection in backyard chickens. Asian Pac J Trop Biomed. 2014.

[53] Harper M, St Michael F, John M et al. Pasteurella multocida Heddleston serovar 3 and 4 strains share a common lipopolysaccharide biosynthesis locus but display both inter- and intrastrain lipopolysaccharide heterogeneity. J Bacteriol. 2013.

[54] Wang Y, Zhu J, Lu C et al. Evidence of circulation of an epidemic strain of Pasteurella multocida in Jiangsu, China by multi-locus sequence typing (MLST). Infect Genet Evol. 2013.

[55] Johnson TJ, Abrahante JE, Hunter SS et al. Comparative genome analysis of an avirulent and two virulent strains of avian Pasteurella multocida reveals candidate genes involved in fitness and pathogenicity. BMC Microbiol. 2013.

[56] Varga Z, Volokhov DV, Stipkovits L et al. Characterization of Pasteurella multocida strains isolated from geese. Vet Microbiol. 2013.

[57] Gong Q, Qu N, Niu M et al. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida. Vet Immunol Immunopathol. 2013.

[58] Tatum FM, Tabatabai LB, Briggs RE. Cross-protection against fowl cholera disease with the use of recombinant Pasteurella multocida FHAB2 peptides vaccine. Avian Dis. 2012.

[59] Chrzastek K, Kuczkowski M, Wieliczko AK et al. Molecular epidemiologic investigation of Polish avian Pasteurella multocida strains isolated from fowl cholera outbreaks showing restricted geographical and host-specific distribution. Avian Dis. 2012.

[60] Hatfaludi T, Al-Hasani K, Gong L et al. Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE. PLoS One. 2012.

[61] Guo D, Lu Y, Zhang A et al. Identification of genes transcribed by Pasteurella multocida in rabbit livers through the selective capture of transcribed sequences. FEMS Microbiol Lett. 2012.

[62] Jaglic Z, Jeklova E, Christensen H et al. Host response in rabbits to infection with Pasteurella multocida serogroup F strains originating from fowl cholera. Can J Vet Res. 2011.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.